NDC 55289-481-60
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-481
- Requested NDC
- 55289-481-60
- Package NDCs from labels
- 55289-481-60
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-481-30 | EA - Each | 55289-481 | 07a64ede-48e8-4037-90d9-a2e69c8fba30 | 1 | 2012-07-24 |
| 55289-481-60 | EA - Each | 55289-481 | 2663740b-cd0e-41c2-a485-f06ffb45344f | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| telmisartan | TELMISARTAN | PD-Rx Pharmaceuticals, Inc. | 56a72ddf-c2a2-45ce-91b1-1fcfbff52c10 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SULINDAC | SULINDAC | PD-Rx Pharmaceuticals, Inc. | eb7acb87-6565-4524-a91a-02064ea8bd1a | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SULINDAC | SULINDAC | PD-Rx Pharmaceuticals, Inc. | 1fffe88d-50c8-45cf-ac7c-a62b665c89a8 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | PD-Rx Pharmaceuticals, Inc. | 700aad61-fa8c-4ded-87b8-da966093075a | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydroxyzine hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 44c63e67-a9e0-4a4f-b34e-2ca60a981766 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | PD-Rx Pharmaceuticals, Inc. | d551f3d0-9503-45bd-b701-dfed4c8a5e1e | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nitrofurantoin | NITROFURANTOIN | PD-Rx Pharmaceuticals, Inc. | 37606c6f-0d85-4314-94ae-f7732c7bc8d5 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nitrofurantoin | NITROFURANTOIN | PD-Rx Pharmaceuticals, Inc. | d88348a0-6ab4-4490-9325-1f14a541b0a5 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | PD-Rx Pharmaceuticals, Inc. | 38c838a4-9943-445a-8e80-e823d56eeaa5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Esomeprazole Magnesium | ESOMEPRAZOLE MAGNESIUM | PD-Rx Pharmaceuticals, Inc. | fdea1f5f-b717-4d49-8d70-0b373c959bf0 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| BISOPROLOL FUMARATE | BISOPROLOL FUMARATE | PD-Rx Pharmaceuticals, Inc. | c8fa858c-7e42-4134-9fc6-604a11a66fe2 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 747fdc13-7c3a-4672-b50c-31c51037bda2 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| BISOPROLOL FUMARATE | BISOPROLOL FUMARATE | PD-Rx Pharmaceuticals, Inc. | 6566dcbe-3e25-4828-9c10-3d041000bc77 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | PD-Rx Pharmaceuticals, Inc. | dc4430cc-8238-4d6d-99ff-bbb9d0b51bd1 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | e899da81-a28e-4a7e-a0e6-ed6d557c0bcd | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 828f0ee1-b9fc-4743-9394-fc086bcf5345 | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 02e233c4-48d1-456d-8fc8-f99a06ef854a | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.